EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 36 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $50 | -88.1% | 71,700 | -84.7% | 0.00% | -100.0% |
| Q1 2023 | $419 | +15.4% | 467,682 | +52.2% | 0.00% | – |
| Q4 2022 | $363 | -100.0% | 307,300 | +131.3% | 0.00% | -100.0% |
| Q3 2021 | $888,000 | +210.5% | 132,884 | +295.2% | 0.00% | – |
| Q2 2021 | $286,000 | -69.8% | 33,625 | -68.5% | 0.00% | -100.0% |
| Q1 2021 | $946,000 | -48.7% | 106,884 | -60.6% | 0.00% | -50.0% |
| Q1 2020 | $1,844,000 | -13.5% | 271,184 | +89.5% | 0.00% | 0.0% |
| Q4 2019 | $2,133,000 | +3.3% | 143,129 | -28.9% | 0.00% | 0.0% |
| Q3 2019 | $2,064,000 | -34.8% | 201,329 | -32.6% | 0.00% | -33.3% |
| Q2 2019 | $3,165,000 | -18.8% | 298,613 | +7.1% | 0.00% | -25.0% |
| Q1 2019 | $3,899,000 | +51.6% | 278,929 | +10.2% | 0.00% | +33.3% |
| Q4 2018 | $2,572,000 | -23.1% | 253,129 | -9.2% | 0.00% | 0.0% |
| Q3 2018 | $3,346,000 | -24.4% | 278,813 | -29.3% | 0.00% | +50.0% |
| Q2 2018 | $4,425,000 | +173.8% | 394,258 | +140.4% | 0.00% | 0.0% |
| Q1 2018 | $1,616,000 | +19.4% | 164,029 | +69.1% | 0.00% | +100.0% |
| Q4 2017 | $1,353,000 | +55.7% | 97,013 | +22.8% | 0.00% | 0.0% |
| Q3 2017 | $869,000 | +369.7% | 79,013 | +237.3% | 0.00% | – |
| Q2 2017 | $185,000 | – | 23,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |